Literature DB >> 20728246

Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations.

Anna M Juern1, Zoey R Glick, Beth A Drolet, Ilona J Frieden.   

Abstract

BACKGROUND: Nevus simplex (NS) is a common birthmark on the forehead, glabella, upper eyelids, and nape. More widespread involvement can be confused with port-wine stains (nevus flammeus) and other vascular birthmarks.
OBJECTIVES: To further categorize the anatomic locations in infants with extensive NS and evaluate for any possible disease associations.
METHODS: We conducted a retrospective review of patients with extensive NS seen at two tertiary care centers.
RESULTS: Twenty-seven patients with extensive NS were identified. All had at least one typical site of involvement: glabella (77.8%), nape (59.3%), and eyelids (55.6%). Additional sites were the scalp, including the vertex, occiput, parietal (66.7%); nose (66.7%); lip (59.2%); lumbosacral skin (55.6%); and upper and mid back (14.8 %). LIMITATIONS: Retrospective nature of the study and relatively small sample size.
CONCLUSIONS: We propose the term "nevus simplex complex" for NS with more widespread involvement beyond the typical sites. Consistent use of the term "nevus simplex" will aid in correct diagnosis and appropriate management of these birthmarks.
Copyright © 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728246     DOI: 10.1016/j.jaad.2009.08.066

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

Review 1.  Classification of Vascular Anomalies: An Update.

Authors:  Jack E Steiner; Beth A Drolet
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

2.  Cutaneous lesions and disorders in healthy neonates and their relationships with maternal-neonatal factors: a cross-sectional study.

Authors:  Rita Ábrahám; Angéla Meszes; Zita Gyurkovits; Judit Bakki; Hajnalka Orvos; Zsanett Renáta Csoma
Journal:  World J Pediatr       Date:  2017-10-20       Impact factor: 2.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.